It is widely believed that EPA and DHA regulate energy metabolism, and have advantages on anti-inflammation, promoting insulin secretion, and enhancing peripheral insulin sensitivity, resulting in reduced risk of a variety of metabolic diseases such as CVD, T2D, hyperlipidemia, and even cancer (13, 14). The gene discussed is INS; the disease is hyperlipidemia.